摘要 |
Compounds represented by general formula (I) and pharmaceutically acceptable salts thereof, wherein n is an integer of 0 to 5; X represents oxygen or sulfur; R<1> represents hydrogen or C1-5 alkyl; R<2> represents C1-5 alkyl; and R<3> represents C3-8 cylcoalkyl. These 4-nitrosulfonanilide derivatives and the salts thereof show little side effects such as digestive disorders, withstand the administration over a long period of time, are highly safe, and have, for example, anti-inflammatory, anti-pyretic and analgetic effects.
|
申请人 |
TAISHO PHARMACEUTICAL CO., LTD.;YOSHIKAWA, KENSEI;HASEGAWA, MASAHIRO;SUZUKI, MASATOSHI;SHIMAZAKI, YOUICHI;OHTANI, MARIKO;SAITO, SHIUJI;GOI, MASAMI |
发明人 |
YOSHIKAWA, KENSEI;HASEGAWA, MASAHIRO;SUZUKI, MASATOSHI;SHIMAZAKI, YOUICHI;OHTANI, MARIKO;SAITO, SHIUJI;GOI, MASAMI |